An inside look at how the market's most feared short seller decides which stocks to target

Business Insider -

Business Insider—Andrew Left, the world-famous short seller and founder of Citron Research, has made a name for himself by writing market-moving reports on companies. His most high-profile success was the series of reports he wrote on Valeant Pharmaceuticals, which ended up coming under fire for the fraud he helped highlight. The company's stock has dropped 90% from Left's initial publication date. In an exclusive interview with Business Insider, Left shed some light on his process for identifying short targets,...

This Is What The Slow-Motion LBO Of The Stock Market Looks Like. When it comes to stock buybacks - an increasingly politically charged topic - 2018 has already been a historic year: as we first reported three months ago, as a result of Trump tax reform which made offshore cash repatriation far more economical, corporations would use much of this redomiciled cash to buyback $650 billion of their own stock in 2018, an all time high (for an extended analysis of the market and political implications of record cash flows, see ""Day Of Reckoning" Nears As Goldman...